Viruses, variants and vaccines
| dc.contributor.author | Cowan, Don A. | |
| dc.contributor.author | Burton, Stephanie G. | |
| dc.contributor.author | Rybicki, E.P. | |
| dc.contributor.author | Williamson, A.-L. | |
| dc.contributor.author | Dorrington, R.A. | |
| dc.contributor.author | Pepper, Michael Sean | |
| dc.contributor.email | don.cowan@up.ac.za | en_US |
| dc.date.accessioned | 2022-11-21T13:03:45Z | |
| dc.date.available | 2022-11-21T13:03:45Z | |
| dc.date.issued | 2021-05 | |
| dc.description.abstract | The current SARS-CoV-2 pandemic has brought a number of major global clinical, sociological and economic issues into sharp focus. We address some of these issues, focusing on short-term factors such as virus mutations and vaccine efficacy, and also considering the longer-term implications of the current pandemic. We discuss societal responses to the presence of a pathogen that will probably remain in circulation for decades or longer, and to future new emergent viruses. | en_US |
| dc.description.department | Biochemistry | en_US |
| dc.description.department | Genetics | en_US |
| dc.description.department | Immunology | en_US |
| dc.description.department | Microbiology and Plant Pathology | en_US |
| dc.description.librarian | am2022 | en_US |
| dc.description.sponsorship | The South African Medical Research Council and the National Research Foundation. | en_US |
| dc.description.uri | http://www.samj.org.za | en_US |
| dc.identifier.citation | Cowan, D.A., Burton, S.G., Rybicki, E.P. et al. 2021, 'Viruses, variants and vaccines', South African Medical Journal, vol. 111, no. 5, pp. 409-411, doi : 10.7196/SAMJ.2021.v111i5.15578. | en_US |
| dc.identifier.issn | 0256-9574 (print) | |
| dc.identifier.issn | 2078-5135 (online) | |
| dc.identifier.other | 10.7196/SAMJ.2021.v111i5.15578 | |
| dc.identifier.uri | https://repository.up.ac.za/handle/2263/88399 | |
| dc.language.iso | en | en_US |
| dc.publisher | Health and Medical Publishing Group | en_US |
| dc.rights | © 2021 Health & Medical Publishing Group. This work is licensed under a Creative Commons Attribution-NonCommercial Works License (CC BY-NC 3.0). | en_US |
| dc.subject | Vaccine | en_US |
| dc.subject | Virus | en_US |
| dc.subject | Pandemic | en_US |
| dc.subject | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | en_US |
| dc.title | Viruses, variants and vaccines | en_US |
| dc.type | Article | en_US |